Numinus Wellness Inc. (TSX: NUMI)

Market Cap	17.73M
Revenue (ttm)	22.48M
Net Income (ttm)	-25.45M
Shares Out	322.32M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,981,210
Open	0.0800
Previous Close	0.0800
Day's Range	0.0500 - 0.0800
52-Week Range	0.0250 - 0.2000
Beta	1.54
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About Numinus Wellness

Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assist...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1964
• Employees: 16
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: NUMI

Financial Performance

In 2023, Numinus Wellness's revenue was 23.18 million, an increase of 256.95% compared to the previous year's 6.49 million. Losses were -30.26 million, -32.59% less than in 2022.